Smithfield Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Smithfield Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18K	Hold	114	–	–	﹤0.01%	811
2026 Q1	$15K	Sell	114 -5	-4%	-$624	﹤0.01%	834
2025 Q4	$15K	Buy	119 +5	+4%	+$573	﹤0.01%	828
2025 Q3	$11K	Hold	114	–	–	﹤0.01%	852
2025 Q2	$9K	Hold	114	–	–	﹤0.01%	886
2025 Q1	$9K	Hold	114	–	–	﹤0.01%	883
2024 Q4	$10K	Hold	114	–	–	﹤0.01%	874
2024 Q3	$11K	Hold	114	–	–	﹤0.01%	829
2024 Q2	$11K	Hold	114	–	–	﹤0.01%	810
2024 Q1	$11K	Hold	114	–	–	﹤0.01%	830
2023 Q4	$10K	Sell	114 -54	-32%	-$4.01K	﹤0.01%	833
2023 Q3	$12K	Hold	168	–	–	﹤0.01%	782
2023 Q2	$13K	Hold	168	–	–	﹤0.01%	785
2023 Q1	$13K	Buy	168 +114	+211%	+$9.46K	﹤0.01%	747
2022 Q4	$4K	Hold	54	–	–	﹤0.01%	926
2022 Q3	$4K	Buy	+54	New	+$4.55K	﹤0.01%	959

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Smithfield Trust's XBI Position: Q2 2026 in Review

Smithfield Trust held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 114 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #811.

Smithfield Trust first reported a position in XBI in Q3 2022 and has held it in 16 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Smithfield Trust held 114 shares of State Street SPDR S&P Biotech ETF worth $18K as of Q2 2026.
Smithfield Trust left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Smithfield Trust's portfolio in Q2 2026, its #811 holding.
Smithfield Trust first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and has held it in 16 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Smithfield Trust's 13F filing for Q2 2026, filed 5 Aug 2026.